|
FOXRED2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
2.810500E-04 |
| Normal-vs-Stage3 |
1.64535052249448E-12 |
| Normal-vs-Stage4 |
9.06659969324153E-10 |
| Stage1-vs-Stage2 |
4.604300E-02 |
| Stage1-vs-Stage3 |
8.524200E-01 |
| Stage1-vs-Stage4 |
6.717000E-01 |
| Stage2-vs-Stage3 |
7.570100E-02 |
| Stage2-vs-Stage4 |
1.394230E-01 |
| Stage3-vs-Stage4 |
7.950200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.63030000055464E-07 |
| Normal-vs-Asian |
2.67689981292563E-10 |
| Caucasian-vs-AfricanAmerican |
9.335000E-01 |
| Caucasian-vs-Asian |
7.611800E-01 |
| AfricanAmerican-vs-Asian |
7.821800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.10850250989847E-11 |
| Normal-vs-Female |
1.62525548574877E-12 |
| Male-vs-Female |
3.134000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.87736542662287E-12 |
| Normal-vs-Age(41-60Yrs) |
3.17523785042795E-14 |
| Normal-vs-Age(61-80Yrs) |
1.39239999996654E-06 |
| Normal-vs-Age(81-100Yrs) |
1.220870E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.640600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.105900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.288400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.996400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.507800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.517200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.280800E-01 |
| Classical-VS-Follicular |
2.330500E-02 |
| Classical-VS-Other |
3.968600E-01 |
| Classical-VS-Normal |
1.62481139653892E-12 |
| Tall-VS-Follicular |
9.838600E-03 |
| Tall-VS-Other |
2.673000E-01 |
| Tall-VS-Normal |
3.02424751907893E-13 |
| Follicular-VS-Other |
2.574100E-02 |
| Follicular-VS-Normal |
2.32440000003109E-06 |
| Other-VS-Normal |
5.74239999999726E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.1825995738235E-10 |
| Normal-vs-N1 |
1.63080660087189E-12 |
| N0-vs-N1 |
4.324000E-03 |
|
|
